key: cord-1027607-kn1himab authors: Kotlyar, Alexander; Tal, Oded; Tal, Reshef title: Vertical transmission of COVID-19, a response date: 2020-11-20 journal: Am J Obstet Gynecol DOI: 10.1016/j.ajog.2020.11.017 sha: e8da4511e72a5dd8a756e46768beab0f4eca999d doc_id: 1027607 cord_uid: kn1himab nan combined in a quantitative synthesis using fixed or random effects models to obtain estimates of 50 prevalence as we accomplished in our study using both case series and cohort studies. This same 51 group cited how case series can be used in a meta-analysis to determine a prevalence estimate 52 such as for mortality following aortic transection (2). Therefore, we disagree with his argument 53 that case series should not be included in determining prevalence estimates. To do so would 54 discard potential vital information in the setting of such a novel emerging disease as 55 particularly in the absence of high quality evidence regarding vertical transmission. 56 As to our methodological quality assessment of study bias risk, Mr. Martinez-Portilla's 57 assessment misses a crucial point explicitly stated in our paper. We used the modified-58 Newcastle-Ottawa scale which is designed to assess case series and has been validated in prior 59 systematic reviews and meta-analyses cited in our methods section (2). While the Joanna Briggs 60 Institute (JBI) critical appraisal tool has been proposed as a method to assess bias in case-series, 61 we have not found any evidence that it is a superior tool than the modified Newcastle-Ottawa 62 scale (3). 63 As far as the third point regarding our pooled estimate result (3.2%) for COVID-19 64 positivity in neonatal nasopharyngeal (NP) swabs, our meta-analysis was conducted using the 65 most recent version of MedCalc software, which uses the commonly used Freeman-Tukey 66 transformation (arcsine-based square root transformation) to calculate the weighted summary in an attempt to replicate our results was based on adding an arbitrary continuity correction 69 factor (0.5) to the number of observed COVID-19 cases in each study that has zero (0) cases of 70 COVID-19. However, this fixed correction method has been shown by Sweeting et al. to have 71 the undesirable effect of biasing study estimates towards no difference and artificially inflating 72 the weight of each such zero study when the sample size is large (4). Here are two examples: 73 Using the arcsine square root transformation used in our study, the Ferazzi study (n=42, k=3) and 74 the London study (n=48, k=0) have similar relative weights -4.41% and 5.03% respectively 75 ( Figure 3) (1). On the other hand, the 0.5 continuity correction factor method proposed results in 76 1.3% and 10.5% respectively, which is counterintuitive and creates obvious bias. In another 77 example using the arcsine square root transformation, the Yan study (n=86, k=0) has a weight of 78 8.93% while the Knight study (n=244, k=12), which is the largest study in the meta-analysis, has 79 a weight of 25.2% (Figure 3) (1). On the other hand, the 0.5 continuity correction factor method 80 results in a relative weight of 33.1% for the smaller Yan (zero) study, and only 11.0% relative 81 weight for the larger Knight study. Thus, using the 0.5 correction as proposed by Portilla is simply wrong and clearly inflates the relative weights of the zero studies, resulting in 83 underestimation of the pooled COVID-19 neonatal NP positivity proportion. Notably, in a recent 84 CDC report (November 2, 2020) representing the largest longitudinal data to date on pregnant 85 women diagnosed with COVID-19 from the Surveillance for Emerging Threats to Mothers and 86 Network (SET-NET) 87 (https://www.cdc.gov/mmwr/volumes/69/wr/mm6944e2.htm), SARS-CoV-2 infection was found 88 in 2.6% (16 out of 610) among neonates known to have been tested for SARS-CoV-2, which is 89 very similar to the pooled estimates reported in our study (3.2%). Vertical 97 Transmission of COVID-19: A Systematic Review and Meta-Analysis Methodological quality and synthesis of 100 case series and case reports Methodological 102 quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Database 103 System Rev Implement Rep What to add to nothing? Use and avoidance of 105 continuity corrections in meta-analysis of sparse data